Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeWGSGeneDx$128.66+6.6%$93.85$28.86▼$130.33$3.47B2.021.04 million shs1.68 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceWGSGeneDx+6.58%+1.82%+55.11%+79.69%+272.93%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationWGSGeneDx2.1879 of 5 stars1.42.00.00.02.84.21.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceWGSGeneDx 2.75Moderate Buy$101.63-21.01% DownsideCurrent Analyst Ratings BreakdownLatest WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/4/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$110.00 ➝ $120.007/30/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $95.007/9/2025WGSGeneDxPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$110.006/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.00(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookWGSGeneDx$305.45M12.10$1.09 per share117.97$9.65 per share13.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateWGSGeneDx-$52.29M$0.052,573.2061.56N/A0.39%16.51%9.35%11/4/2025 (Estimated)Latest WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025WGSGeneDx$0.10$0.50+$0.40$0.36$86.00 million$102.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioWGSGeneDx0.192.872.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipWGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipWGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableWGSGeneDx1,20028.73 million20.22 millionOptionableWGS HeadlinesRecent News About These CompaniesGeneDx Holdings Corp. $WGS Shares Purchased by Algert Global LLCAugust 22 at 4:43 AM | marketbeat.com197,912 Shares in GeneDx Holdings Corp. $WGS Acquired by Nuveen LLCAugust 22 at 3:48 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 21 at 6:39 PM | globenewswire.comGeneDx (NASDAQ:WGS) Sets New 1-Year High - Here's What HappenedAugust 21 at 11:43 AM | marketbeat.comRussell Investments Group Ltd. Raises Holdings in GeneDx Holdings Corp. $WGSAugust 21 at 3:59 AM | marketbeat.comInvesco Ltd. Acquires 134,228 Shares of GeneDx Holdings Corp. $WGSAugust 20 at 3:42 AM | marketbeat.comCathie Wood’s ARK Investment buys 170K shares of GeneDx todayAugust 19, 2025 | msn.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 18, 2025 | prnewswire.comStocks With Rising Relative Price Strength: ProgynyAugust 18, 2025 | msn.comThompson Davis & CO. Inc. Sells 6,980 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)August 17, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Purchased by Legal Advantage Investments Inc.August 17, 2025 | marketbeat.comLord Abbett & CO. LLC Lowers Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS)August 17, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Stock Position Lifted by LPL Financial LLCAugust 17, 2025 | marketbeat.comVirtu Financial LLC Purchases New Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)August 16, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Hits New 1-Year High - Time to Buy?August 15, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives $101.63 Consensus Price Target from BrokeragesAugust 15, 2025 | americanbankingnews.comCorvex Management starts new position in Oracle, piled up on Amazon in Q2 movesAugust 14, 2025 | msn.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...August 14, 2025 | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsAugust 14, 2025 | globenewswire.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation - WGSAugust 13, 2025 | prnewswire.comGeneDx Holdings Corp. (NASDAQ:WGS) Stock Position Reduced by Informed Momentum Co LLCAugust 13, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWGS Company DescriptionsGeneDx NASDAQ:WGS$128.66 +7.94 (+6.58%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$128.02 -0.63 (-0.49%) As of 08/22/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet’s Breakout Potential: From Laggard to AI Leader After Earnings Miss, Walmart Is Still a Top Consumer Staples Play Should You Join Buffett and Invest in Constellation Brands? Can Identity Security Fuel CrowdStrike’s Next Growth Phase? 3 Robotics Stocks at the Heart of the Robotics Revolution Analog Devices and an AI-Driven Semiconductor Supercycle Shopify’s Risk-Reward Profile Is Suddenly Red Hot 3 Reasons Salesforce Is a Bargain Right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access